Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)

Market Cap	4.18B
Revenue (ttm)	1.09B
Net Income (ttm)	11.04M
Shares Out	309.54M
EPS (ttm)	0.04
PE Ratio	378.21
Forward PE	n/a
Dividend	0.20 (1.48%)
Ex-Dividend Date	May 29, 2025

Volume	13,039,800
Average Volume	36,027,267
Open	15.42
Previous Close	13.27
Day's Range	13.15 - 15.42
52-Week Range	7.81 - 18.18
Beta	0.59
RSI	45.28
Earnings Date	Aug 29, 2025

About SHE:002900

Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical product and medical devices in China. The company offers various drugs for nervous system, cardiovascular system, musculoskeletal system, systemic anti-infective, basic infusions, nutritional infusion, anti-tumor and immunomodulators, digestive tract, metabolism, etc. It also produces and sells cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 2,522
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002900

Financial Performance

In 2024, SHE:002900's revenue was 1.13 billion, a decrease of -4.58% compared to the previous year's 1.19 billion. Earnings were 58.68 million, a decrease of -20.35%.